No Data
12 Health Care Stocks Moving In Monday's Pre-Market Session
 Gainers Cerevel Therapeutics Hldg (NASDAQ:CERE) stock increased by 18.0% to $39.49 during Monday's pre-market session. The market value of their outstanding shares is at $5.8 billion.Eargo (NASDAQ:
Top Premarket Decliners
08:02 AM EDT, 08/08/2022 (MT Newswires) -- NuZee (NUZE) shares slumped 23% after the company priced a $3.4 million common stock offering. Marker Therapeutic (MRKR) shares tumbled 18%, paring Friday's
Why Is NuZee Down By Over 21%: Here Are 38 Stocks Moving Premarket
Gainers Bonso Electronics International Inc. (NASDAQ:BNSO) shares rose 46% to $6.98 in pre-market trading after jumping around 46% on Friday. The company recently said it expects unaudited comprehensi
Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday
Gainers Cooper-Standard Holdings Inc. (NYSE:CPS) jumped 69.6% to close at $8.53 on Friday following better-than-expected Q2 results.Intelligent Living Application Group Inc. (NASDAQ:ILAG) surged 64.4%
12 Health Care Stocks Moving In Friday's Intraday Session
 Gainers Marker Therapeutics (NASDAQ:MRKR) shares increased by 54.3% to $0.51 during Friday's regular session. The current volume of 63.7 million shares is 16959.7% of Marker Therapeutics's average
Why Cooper-Standard Is Trading Higher By 70%, Here Are 81 Stocks Moving In Friday's Mid-Day Session
Gainers Assure Holdings Corp. (NASDAQ:IONM) shares jumped 88.8% to $3.9650 after jumping around 104% on Thursday.Cooper-Standard Holdings Inc. (NYSE:CPS) rose 70.4% to $8.57 following better-than-expe
Dow Drops 150 Points, Crude Oil Rises Over 2%
U.S. stocks traded lower midway through trading, following the release of jobs data The Dow traded down 0.48% to 32,571.32 while the NASDAQ fell 1.53% to 12,525.77. The S&P also fell, dropping, 0.
Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus FDA Signs Off Marker Therapeutics Cell Therapy Study In Lymphoma Setting The FDA cleared Marker Therap
Marker Therapeutics Shares Climb Over 50% After FDA Approves IND for MT-601
By Stephen Nakrosis Shares of Marker Therapeutics Inc. were trading higher Friday, continuing momentum from the after-hours market Thursday following news the U.S. Food and Drug Administration approv
Wall Street Tumbles Pre-Bell as US Economy Adds 528,000 Jobs
09:27 AM EDT, 08/05/2022 (MT Newswires) -- US stocks turned lower ahead of Friday's opening bell as traders digested monthly jobs data for clues on the health of the US economy. Dow Jones Industrial A
Loading...